Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Severe Acute Respiratory Syndrome(SARS) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Severe Acute Respiratory Syndrome(SARS) Therapeuticsmarket, defines the market attractiveness level of Severe Acute Respiratory Syndrome(SARS) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Severe Acute Respiratory Syndrome(SARS) Therapeutics industry, describes the types of Severe Acute Respiratory Syndrome(SARS) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Severe Acute Respiratory Syndrome(SARS) Therapeutics market and the development prospects and opportunities of Severe Acute Respiratory Syndrome(SARS) Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Severe Acute Respiratory Syndrome(SARS) Therapeutics market in Chapter 13.
By Player:
Protein Sciences Corporation
Humabs BioMed SA
CEL-SCI Corporation
GeneCure LLC
Phelix Therapeutics, LLC
By Type:
CEL-1000
D-3252
FDX-000
INO-4500
LCA-60
Others
By End-User:
Hospital
Clinic
Research Center
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Severe Acute Respiratory Syndrome(SARS) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Severe Acute Respiratory Syndrome(SARS) Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption (2017-2022)
-
7.2 United States Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption (2017-2022)
-
7.3 Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption (2017-2022)
-
7.4 China Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption (2017-2022)
-
7.5 Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption (2017-2022)
-
7.6 India Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption (2017-2022)
-
7.7 South Korea Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption (2017-2022)
8 Region and Country-wise Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast (2022-2028)
9 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CEL-1000 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global D-3252 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global FDX-000 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global INO-4500 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global LCA-60 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Center Consumption and Growth Rate (2017-2022)
10 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CEL-1000 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global D-3252 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global FDX-000 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global INO-4500 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global LCA-60 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
11 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Competitive Analysis
-
14.1 Protein Sciences Corporation
-
14.1.1 Protein Sciences Corporation Company Details
-
14.1.2 Protein Sciences Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Protein Sciences Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
-
14.2 Humabs BioMed SA
-
14.2.1 Humabs BioMed SA Company Details
-
14.2.2 Humabs BioMed SA Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Humabs BioMed SA Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
-
14.3 CEL-SCI Corporation
-
14.3.1 CEL-SCI Corporation Company Details
-
14.3.2 CEL-SCI Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 CEL-SCI Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
-
14.4 GeneCure LLC
-
14.4.1 GeneCure LLC Company Details
-
14.4.2 GeneCure LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GeneCure LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
-
14.5 Phelix Therapeutics, LLC
-
14.5.1 Phelix Therapeutics, LLC Company Details
-
14.5.2 Phelix Therapeutics, LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Phelix Therapeutics, LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Severe Acute Respiratory Syndrome(SARS) Therapeutics
-
Figure Severe Acute Respiratory Syndrome(SARS) Therapeutics Picture
-
Table Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption by Country (2017-2022)
-
Figure United States Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Severe Acute Respiratory Syndrome(SARS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CEL-1000 Consumption and Growth Rate (2017-2022)
-
Figure Global D-3252 Consumption and Growth Rate (2017-2022)
-
Figure Global FDX-000 Consumption and Growth Rate (2017-2022)
-
Figure Global INO-4500 Consumption and Growth Rate (2017-2022)
-
Figure Global LCA-60 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global CEL-1000 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global D-3252 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FDX-000 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global INO-4500 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global LCA-60 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Protein Sciences Corporation (Foundation Year, Company Profile and etc.)
-
Table Protein Sciences Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protein Sciences Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
-
Table Humabs BioMed SA (Foundation Year, Company Profile and etc.)
-
Table Humabs BioMed SA Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Humabs BioMed SA Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
-
Table CEL-SCI Corporation (Foundation Year, Company Profile and etc.)
-
Table CEL-SCI Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table CEL-SCI Corporation Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
-
Table GeneCure LLC (Foundation Year, Company Profile and etc.)
-
Table GeneCure LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GeneCure LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
-
Table Phelix Therapeutics, LLC (Foundation Year, Company Profile and etc.)
-
Table Phelix Therapeutics, LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Phelix Therapeutics, LLC Severe Acute Respiratory Syndrome(SARS) Therapeutics Product and Service
-
